Sucrobind 500 mg Chewable Tablet 6's belongs to the class of medications called mineral supplements indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis.
Sucrobind 500 mg Chewable Tablet 6's contains 'sucroferric oxyhydroxide'. It helps to lower phosphate levels in the blood and prevents complications caused by high phosphate levels in the blood, especially in dialysis patients who are unable to eliminate excess phosphate levels.
Sucrobind 500 mg Chewable Tablet 6's should be taken as prescribed by your doctor. Sucrobind 500 mg Chewable Tablet 6's can cause side effects such as diarrhoea, nausea, vomiting, constipation, and indigestion in some cases. These side effects are not universal and vary from person to person. Please consult your doctor if you experience any of the side effects persistently.
Do not take Sucrobind 500 mg Chewable Tablet 6's if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Before using this medication, inform your doctor of any medical issues you may have. Consult your doctor if you are pregnant or breastfeeding. The safety and efficacy of Sucrobind 500 mg Chewable Tablet 6's in children blow 2years have not been established.